Lars Jørgen Østergaard

Aarhus University - Department of Infectious Diseases

Aarhus

Denmark

Aarhus University - Department of Clinical Medicine

SCHOLARLY PAPERS

5

DOWNLOADS

815

SSRN CITATIONS

0

CROSSREF CITATIONS

0

Scholarly Papers (5)

1.

Levels of SARS-CoV-2 Antibodies Among Fully-Vaccinated Individuals With Delta or Omicron Variant Breakthrough Infections: A Prospective Cohort Study

Number of pages: 18 Posted: 25 Mar 2022
Aarhus University - Department of Infectious Diseases, University of Copenhagen - Centre of Excellence for Health, Immunity and Infections CHIP, Aalborg University - Department of Infectious Diseases, University of Copenhagen - Department of Infectious Diseases, Zealand University Hospital - Department of Infectious Diseases, Zealand University Hospital - Department of Medicine, Zealand University Hospital - Department of Medicine, University of Copenhagen - Department of Cardiology, University of Copenhagen - Department of Cardiology, Aalborg University - Department of Infectious Diseases, Aalborg University - Department of Infectious Diseases, Odense University Hospital - Department of Infectious Diseases, Odense University Hospital - Department of Infectious Diseases, Odense University Hospital - Department of Infectious Diseases, Aarhus University - Department of Infectious Diseases, Aarhus University - Department of Infectious Diseases, Aarhus University - Department of Infectious Diseases, Aarhus University - Department of Infectious Diseases, University of Copenhagen - Department of Clinical Medicine, Aarhus University Hospital - Department of Clinical Immunology, University of Copenhagen - Department of Public Health, Aarhus University - Department of Infectious Diseases, Aarhus University - Department of Infectious Diseases, Odense University Hospital - Department of Infectious Diseases, University of Copenhagen - Centre of Excellence for Health, Immunity and Infections CHIP and Aarhus University - Department of Infectious Diseases
Downloads 359 (123,354)

Abstract:

Loading...

SARS-CoV-2, COVID-19, vaccination, antibody, serology, breakthrough infection, Omicron, Delta

2.

Coenzyme Q10 as Treatment of Post COVID-19 Condition

Number of pages: 29 Posted: 01 Aug 2022
Aarhus University - Department of Infectious Diseases, Aarhus University - Department of Infectious Diseases, Aarhus University - Department of Infectious Diseases, Aarhus University - Department of Infectious Diseases, Aarhus University - Department of Infectious Diseases, Aarhus University - Department of Infectious Diseases and Aarhus University - Department of Infectious Diseases
Downloads 213 (209,110)

Abstract:

Loading...

Post COVID-19 condition, Coenzyme Q10, mitochondria, COVID-19

3.

Diagnostic Performance, User Acceptability, and Safety of Unsupervised SARS-CoV-2 Rapid Antigen Detecting Tests Performed at Home

Number of pages: 20 Posted: 30 Aug 2021
Aarhus University - Department of Infectious Diseases, Aarhus University - Aarhus University Hospital, Aarhus University - Aarhus University Hospital, Aarhus University - Department of Infectious Diseases and Aarhus University - Aarhus University Hospital
Downloads 171 (253,746)

Abstract:

Loading...

4.

Persistent Symptoms and Sequelae after SARS-CoV-2 Infection Not Requiring Hospitalization: Results from Testing Denmark, a Danish Cross-Sectional Survey

Number of pages: 18 Posted: 17 Mar 2022
Roskilde University - Department of Science and Environment, University of Copenhagen - Department of Cardiology, Statens Serum Institut - Infectious Disease Epidemiology & Prevention, University of Copenhagen - Department of Cardiology, Aalborg University - Department of Infectious Diseases, Aarhus University - Department of Infectious Diseases, Statens Serum Institut, University of Copenhagen - Department of Clinical Medicine, Statens Serum Institut, University of Copenhagen - Department of Clinical Immunology, Statens Serum Institut, Odense University Hospital - Department of Infectious Diseases, Statens Serum Institut, Statens Serum Institut, Zealand University Hospital - Department of Infectious Diseases, University of Copenhagen - Department of Public Health, Statens Serums Institut - Department of Infectious Disease Epidemiology, University of Copenhagen - Department of Infectious Diseases, University of Copenhagen - Department of Cardiology, University of Copenhagen - Department of Clinical Medicine, University of Copenhagen - Department of Clinical Medicine, Statens Serum Institut - Infectious Disease Epidemiology & Prevention, Aarhus University Hospital - Department of Clinical Immunology, Statens Serum Institut, Statens Serum Institut - Infectious Disease Epidemiology & Prevention, Statens Serum Institut, Statens Serum Institut, Roskilde University - Department of Science and Environment and University of Copenhagen - Department of Clinical Medicine
Downloads 66 (483,585)

Abstract:

Loading...

COVID-19, SARS-CoV-2, long-COVID, post-COVID syndrome, Post-Acute Sequelae of SARS-CoV-2 infection, PASC, point-of-care-test, POCT, cross-sectional survey, quality of life, Health-related quality of life, SF-12, short-form-12, Testing Denmark, Denmark, propensity scores, Odds ratio, matching, risk factors

5.

Redirector of Vaccine-Induced Effector Responses (RoVER) for Specific Killing of Cellular Targets

Number of pages: 27 Posted: 28 Sep 2022
Aarhus University - Department of Clinical Medicine, Aarhus University - Department of Clinical Medicine, Aarhus University - Department of Clinical Medicine, Aarhus University - Department of Infectious Diseases, affiliation not provided to SSRN, affiliation not provided to SSRN, Aarhus University - Department of Infectious Diseases, Aarhus University - Department of Infectious Diseases, Aarhus University - Department of Infectious Diseases and Aarhus University - Department of Infectious Diseases
Downloads 6 (875,886)

Abstract:

Loading...

Immunotherapy, Vaccine, Cytotoxic T lymphocytes, Redirection, Cancer, HIV-1 infection